Successful sequential tyrosine kinase inhibitors to overcome a rare compound of egfr exon 18–18 and egfr amplification: a case report

HIGHLIGHTS

• who: Pascal Wang from the Integrated University Hospital Verona, Italy have published the Article: Successful sequential tyrosine kinase inhibitors to overcome a rare compound of EGFR exon 18u201318 and EGFR amplification: A case report, in the Journal: (JOURNAL) of 20/01/2022
• future: More research is needed before neratinib can be recommended as a new standard in CMut exon 18-18.

SUMMARY

To clarify the genetic alteration of the tumor, molecular analysis by next-generation sequencing (NGS) of DNA (Tumor Hot Spot MASTR Plus, Multiplicom) was performed on the cervical lymph . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or E-mail:

If you don't have an account, you can create one here.